In addition, GSVA analysis revealed that the biological pathways with differential activation included angiogenesis, cytokine receptors, IgA, and various metabolism factors and these were under different m6A modification modes, indicating that m6A significantly promotes tumour progression through multiple mechanisms, including the immune system. This evidence concerns the gene CD79A and neoplasm.